🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single institution phase I/II study using an ADAM17 inhibitor (IN...
Status
Completed
Location
University of Minnesota Medical Center, Fairview
Start Date
2014-05
Trial ID
NCT02141451
This phase III trial studies rituximab after stem cell transplant and to se...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-11-27
Trial ID
NCT03267433
This is a prospective, interventional study administering 2 doses of the ex...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2018-11-16
Trial ID
NCT03383055
Treatments Being Tested
The investigators hypothesize that prophylactic E-selectin inhibition via a...
Status
Completed
Location
Washington University School of Medicine
Start Date
2021-05-05
Trial ID
NCT04682405
Treatments Being Tested
The purpose of this study is to determine if double autologous then allogen...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2006-10
Trial ID
NCT00482053
Treatments Being Tested
This phase II trial studies autologous peripheral blood stem cell transplan...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2010-03-18
Trial ID
NCT01008462
Treatments Being Tested
Mixed chimerism transplantation is an approach to allogeneic transplants th...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2000-08
Trial ID
NCT00185614
The purpose of this trial is to develop an alternative treatment for patien...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2007-01
Trial ID
NCT00481832
This phase I/II trial studies how well autologous stem cell transplant foll...
Status
Completed
Location
Huntsman Cancer Institute/University of Utah
Start Date
1999-09
Trial ID
NCT00005803
Treatments Being Tested
This phase II trial studies the side-effects and anti-cancer effects of giv...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2008-10
Trial ID
NCT00793572
Treatments Being Tested